BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27126789)

  • 1. Simultaneous quantitative profiling of 20 isoprostanoids from omega-3 and omega-6 polyunsaturated fatty acids by LC-MS/MS in various biological samples.
    Dupuy A; Le Faouder P; Vigor C; Oger C; Galano JM; Dray C; Lee JC; Valet P; Gladine C; Durand T; Bertrand-Michel J
    Anal Chim Acta; 2016 May; 921():46-58. PubMed ID: 27126789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples.
    Leung KS; Galano JM; Durand T; Lee JC
    Free Radic Res; 2015; 49(7):816-26. PubMed ID: 25184341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids.
    Vigor C; Bertrand-Michel J; Pinot E; Oger C; Vercauteren J; Le Faouder P; Galano JM; Lee JC; Durand T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():65-78. PubMed ID: 24856297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into the contribution of isoprostanoids to the health effects of omega 3 PUFAs.
    Joumard-Cubizolles L; Lee JC; Vigor C; Leung HH; Bertrand-Michel J; Galano JM; Mazur A; Durand T; Gladine C
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():111-122. PubMed ID: 28610769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased isoprostanoid levels in brain from murine model of Krabbe disease - Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity.
    Signorini C; Cardile V; Pannuzzo G; Graziano ACE; Durand T; Galano JM; Oger C; Leoncini S; Cortelazzo A; Lee JC; Hayek J; De Felice C
    Free Radic Biol Med; 2019 Aug; 139():46-54. PubMed ID: 31100476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.
    Yen HC; Wei HJ; Lin CL
    Free Radic Res; 2015; 49(7):861-80. PubMed ID: 25812589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential applications of lipid peroxidation products - F
    De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
    Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry.
    Lee YY; Galano JM; Oger C; Vigor C; Guillaume R; Roy J; Le Guennec JY; Durand T; Lee JC
    Lipids; 2016 Nov; 51(11):1217-1229. PubMed ID: 27671161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an LC-ESI(-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs.
    Rund KM; Ostermann AI; Kutzner L; Galano JM; Oger C; Vigor C; Wecklein S; Seiwert N; Durand T; Schebb NH
    Anal Chim Acta; 2018 Dec; 1037():63-74. PubMed ID: 30292316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long chain omega-3 fatty acids and their oxidized metabolites are associated with reduced prostate tumor growth.
    Bilodeau JF; Gevariya N; Larose J; Robitaille K; Roy J; Oger C; Galano JM; Bergeron A; Durand T; Fradet Y; Julien P; Fradet V
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102215. PubMed ID: 33276284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoxia elevates adrenic acid peroxidation in marine fish and is associated with reproductive pheromone mediators.
    Chung ML; Galano JM; Oger C; Durand T; Lee JC
    Mar Drugs; 2015 Apr; 13(4):2215-32. PubMed ID: 25874920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profiling following intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention.
    Gladine C; Newman JW; Durand T; Pedersen TL; Galano JM; Demougeot C; Berdeaux O; Pujos-Guillot E; Mazur A; Comte B
    PLoS One; 2014; 9(2):e89393. PubMed ID: 24558496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?
    Roy J; Le Guennec JY; Galano JM; Thireau J; Bultel-Poncé V; Demion M; Oger C; Lee JC; Durand T
    Biochimie; 2016 Jan; 120():56-61. PubMed ID: 26112019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a LC⁻MS/MS-Based Assay for Quantification of Free and Total Omega 3 and 6 Fatty Acids from Human Plasma.
    Serafim V; Tiugan DA; Andreescu N; Mihailescu A; Paul C; Velea I; Puiu M; Niculescu MD
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30669503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprostanes, neuroprostanes and phytoprostanes: An overview of 25years of research in chemistry and biology.
    Galano JM; Lee YY; Oger C; Vigor C; Vercauteren J; Durand T; Giera M; Lee JC
    Prog Lipid Res; 2017 Oct; 68():83-108. PubMed ID: 28923590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay.
    Musiek ES; Cha JK; Yin H; Zackert WE; Terry ES; Porter NA; Montine TJ; Morrow JD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):95-102. PubMed ID: 14659440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special Issue on "Analytical Methods for Oxidized Biomolecules and Antioxidants" The use of isoprostanoids as biomarkers of oxidative damage, and their role in human dietary intervention studies.
    Galano JM; Lee YY; Durand T; Lee JC
    Free Radic Res; 2015 May; 49(5):583-98. PubMed ID: 25734631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of oxidative stress biomarkers - neuroprostanes and dihomo-isoprostanes - in the urine of elite triathletes after two weeks of moderate-altitude training.
    García-Flores LA; Medina S; Cejuela R; Martínez-Sanz JM; Oger C; Galano JM; Durand T; Casas-Pina T; Martínez-Hernández P; Ferreres F; Gil-Izquierdo Á
    Free Radic Res; 2016; 50(5):485-94. PubMed ID: 26503242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-enzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and α-linolenic acids; bioactivities and potential use as biomarkers.
    Galano JM; Lee JC; Gladine C; Comte B; Le Guennec JY; Oger C; Durand T
    Biochim Biophys Acta; 2015 Apr; 1851(4):446-55. PubMed ID: 25463478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F2-isoprostanes and F4-neuroprostanes as markers of intracranial aneurysm development.
    Syta-Krzyżanowska A; Jarocka-Karpowicz I; Kochanowicz J; Turek G; Rutkowski R; Gorbacz K; Mariak Z; Skrzydlewska E
    Adv Clin Exp Med; 2018 May; 27(5):673-680. PubMed ID: 29790685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.